The SFRN funding mechanism is designed to facilitate multidisciplinary and collaborative approaches to advance basic research, detection, and therapy of strategic areas that are consistent with the AHA mission to be a relentless force for a world of longer, healthier lives. In this context, the Vascular Disease SFRN focuses on PAD and aortopathies that have a major impact on public health, while also having major unmet needs regarding medical therapy. In addition to the funding provided for projects within the 4 years of support, this SFRN will form a legacy by training a cadre of postdoctoral fellows that will continue to develop research careers and provide further insights into mechanisms of PAD and aortic diseases.
|Journal||Arteriosclerosis, Thrombosis, and Vascular Biology|
|State||Published - Mar 1 2020|
Bibliographical noteFunding Information:
The authors are supported by the following Strategically Focused Research Network grants from the American Heart Association: 18SFRN33900085 to M.P. Bonaca, M.A. Creager, P.P. Goodney, M.W. Feinberg, and M.S. Sabatine; 18SFRN33900097 to M.M. McDermott, M.R. Carnethon, C. Leeuwenburgh, and P. Greenland; 18SFRN33900001 to A. Daugherty, N.R. Webb, L.A. Cassis, S.A. LeMaire, and Y.H. Shen; 18SFRN33960373 to J.A. Beckman, J.V. Barnett, D.H. Wasserman, M.S. Freiberg, and Q.S. Wells.
- United States
- diabetes mellitus
- peripheral artery disease
- public health
ASJC Scopus subject areas
- Cardiology and Cardiovascular Medicine